Postmenopausal women treated with combination parathyroid hormone (1–84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS)

Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT

(2012) Stinus Hansen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Six Months of Parathyroid Hormone (1–84) Administered ConcurrentlyVersusSequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial

(2012) Anne L. Schafer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial

(2012) R. D. Chapurlat et al.   OSTEOPOROSIS INTERNATIONAL

Computational finite element bone mechanics accurately predicts mechanical competence in the human radius of an elderly population

(2011) Thomas L. Mueller et al.   BONE

Femoral strength in osteoporotic women treated with teriparatide or alendronate

(2011) Tony M. Keaveny et al.   BONE

Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials

(2011) Longxiang Shen et al.   PLoS One

Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT

(2010) Andrew J. Burghardt et al.   BONE

Stimulation of signal transduction pathways in osteoblasts by mechanical strain potentiated by parathyroid hormone

(2010) Roberto S. Carvalho et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

(2010) A. Michael Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

(2010) Ego Seeman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

(2010) Andrew J Burghardt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

(2010) H. M. Macdonald et al.   OSTEOPOROSIS INTERNATIONAL

Risedronate reduces intracortical porosity in women with osteoporosis

(2009) Babul Borah et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study

(2009) Jan Borggrefe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method

(2008) Joshua A. MacNeil et al.   BONE

Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans

(2008) Tony M Keaveny et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States

(2008) Sarah J Glover et al.   JOURNAL OF BONE AND MINERAL RESEARCH